Hematology Analyzer offers throughput of 120 samples/hr.
Press Release Summary:
Offering 50 parameters, Pentra DX Nexus includes color touchscreen with virtual keyboard and intuitive software, as well as multiple USB ports that enable data transfer and hardware connections. Satisfying accreditation requirements, bench top system can display information related to every sample run. Pop-up window on data manager displays identification, lot number, expiry data of reagents and controls as well as status of quality control at time of every result.
Original Press Release:
Horiba Medical Launches the Pentra DX Nexus Haematology Analyser
The new high throughput Pentra improves process efficiency in Haematology
The new Pentra DX Nexus high throughput haematology analyser from HORIBA Medical
Northampton, UK– Haematology specialists, HORIBA Medical, has launched an advanced high throughput haematology analyser, the Pentra DX Nexus. The new bench-top analyser offers reliability, efficiency and quality, combined with enhanced ease of use and reduced environmental footprint. Offering 50 parameters and a throughput of 120 samples per hour, the Pentra DX Nexus is compatible with Haemcell, HORIBA Medical’s integrated laboratory solution. Its functionality is further enhanced by accompanying new features of the ABX Pentra ML data manager and an optional combination with SPS evolution slide maker/stainer.
As well as providing rapid analysis and meeting laboratory needs for precision and productivity, the Pentra DX Nexus has been designed with ergonomics in mind. The large, colour touch-screen of the integrated computer has a virtual keyboard and intuitive software. In addition, multiple USB ports enable easy data transfer and hardware connections.
Satisfying accreditation requirements, a novel feature is its ability to display information related to every sample run. A pop-up window on the data manager displays: identification; lot number; the expiry date of reagents and controls; as well as the status of quality control at the time of every result. The innovative features on the data manager include rules to provide the operator with advice based directly on ISLH guidelines and enhanced remote access with patient ID protection.
The Pentra DX Nexus has many areas of technological development that not only enhance sample handling and instrument reliability, but also bring benefits to the laboratory environment. For example, the new laser source offers reduced heat and noise output and power consumption, requires minimal space, yet delivers improved and additional parameters. Additional sample racks offered on the instrument are also compatible with most pre- and post-analytical systems available today.
“Resulting from nearly 30 years of understanding and meeting our customers’ individual needs, we hold a wealth of expertise in haematology within our team. Consequently, HORIBA Medical has become a well-respected and renowned specialist in the design and manufacture of automated in vitro diagnostic systems for haematology and chemistry analysis,” said Cleve Wright, UK General Manager of HORIBA Medical. “With its new colour touch screen and smart access to various functionalities, the Pentra Nexus is an exciting addition to our broad range of Pentra haematology analysers. All are designed to meet our many differing customer requirements, both in the laboratory and at the point-of-care.”
For more information please visit http://www.horiba.com/uk/medical.
ABOUT HORIBA Medical - UK:
www.horiba.com/uk/medical
The HORIBA Medical team holds a wealth of expertise in haematology, and increasingly in clinical chemistry. This is due to nearly 30 years of understanding and meeting its customers’ exacting individual diagnostic needs. As a result, HORIBA Medical has become a well-respected and renowned specialist in the design and manufacture of automated in vitro diagnostic systems for haematology and chemistry analysis.
HORIBA Medical now facilitates the entire haematology process, both in the laboratory and at the point of care, from process and analyser optimisation, analysing samples and managing data, including new computer-assisted microscopy options, through to remote monitoring and e-Learning. Furthermore, in addition to NHS and private healthcare settings, HORIBA Medical products are proving their worth in many other areas, including: veterinary diagnostics, sports science, food and beverage, pharma and nutraceuticals, and clinical research.
From compact to high throughput systems, HORIBA Medical continues to successfully evolve, develop and deliver an array of analysers and reagents, as well as data management solutions to meet all needs, enabling LEAN analysis anywhere it is required. Indeed, through its commitment to providing the most comprehensive haematology portfolio available, 2012 will see the launch of a number of new products. These are all designed to provide the best possible solutions within a fast changing IVD world.
HORIBA Medical’s product and service combinations all deliver quality results, flexibility, security and process efficiency. These merits in turn ensure effective clinical decision making, enhanced patient care pathways and improved patient outcomes.
